These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30007116)

  • 21. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
    J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
    Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
    Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
    Duceppe E; Patel A; Chan MTV; Berwanger O; Ackland G; Kavsak PA; Rodseth R; Biccard B; Chow CK; Borges FK; Guyatt G; Pearse R; Sessler DI; Heels-Ansdell D; Kurz A; Wang CY; Szczeklik W; Srinathan S; Garg AX; Pettit S; Sloan EN; Januzzi JL; McQueen M; Buse GL; Mills NL; Zhang L; Sapsford R; Paré G; Walsh M; Whitlock R; Lamy A; Hill S; Thabane L; Yusuf S; Devereaux PJ
    Ann Intern Med; 2020 Jan; 172(2):96-104. PubMed ID: 31869834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.
    Mok Y; Sang Y; Ballew SH; Hoogeveen RC; Ballantyne CM; Rosamond W; Coresh J; Selvin E; Matsushita K
    Am Heart J; 2019 Oct; 216():62-73. PubMed ID: 31404723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.
    Nadruz W; Gonçalves A; Claggett B; Querejeta Roca G; Shah AM; Cheng S; Heiss G; Ballantyne CM; Solomon SD
    Eur J Heart Fail; 2016 Jun; 18(6):629-37. PubMed ID: 27030444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
    Folsom AR; Lutsey PL; Astor BC; Cushman M
    Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
    Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
    J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy.
    Roy DC; Wang TF; Mallick R; Carrier M; Mollanji E; Liu P; Zhang L; Hawken S; Wells P
    Thromb Haemost; 2022 Jul; 122(7):1169-1176. PubMed ID: 35263789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
    Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
    J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers.
    Codognotto M; Piccoli A; Zaninotto M; Mion MM; Ruzza L; Barchita A; Naso A; Plebani M
    J Nephrol; 2010; 23(4):465-71. PubMed ID: 20540041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.